Elafibranor and Glucagon-Like Peptide-1 Receptor Agonists Synergize to Attenuate Hepatic Inflammation and Fibrosis in a Rodent Model of Obesity, Insulin Resistance, and NASH

被引：0
|
作者：
Legry, Vanessa
Descamps, Emeline
Debaecker, Simon
Stankovic-Valentin, Nicolas
Parroche, Peggy
Degallaix, Nathalie
Poulain, Philippe
Staels, Bart
Walczak, Robert
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1817-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1817-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity
    Burcelin, R.
    Gourdy, P.
    OBESITY REVIEWS, 2017, 18 (01) : 86 - 98
  • [22] Glucagon-like peptide-1 receptor agonists and kidney outcomes
    MacIsaac, Richard J.
    Trevella, Philippa
    Ekinci, Elif I.
    JOURNAL OF DIABETES, 2024, 16 (10)
  • [23] Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists
    Vaduganathan, Muthiah
    Patel, Ravi B.
    Singh, Avinainder
    McCarthy, Cian P.
    Qamar, Arman
    Januzzi, James L., Jr.
    Scirica, Benjamin M.
    Butler, Javed
    Cannon, Christopher P.
    Bhatt, Deepak L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (12) : 1596 - 1598
  • [24] The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists
    Fang, Haowen
    Niu, Bing
    Chen, Qin
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (20) : 2921 - 2943
  • [25] LONG-ACTING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISM MITIGATES INFLAMMATION AND FIBROSIS IN MODELS OF NASH AND BILIARY FIBROSIS
    Wang, X. -Y.
    Weng, S. -Y.
    Kim, Y. O.
    Klein, T.
    Schuppan, D.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S278 - S278
  • [26] Hydrocarbon-Stitched Peptide Agonists of Glucagon-Like Peptide-1 Receptor
    Bird, Gregory H.
    Fu, Accalia
    Escudero, Silvia
    Godes, Marina
    Opoku-Nsiah, Kwadwo
    Wales, Thomas E.
    Cameron, Michael D.
    Engen, John R.
    Danial, Nika N.
    Walensky, Loren D.
    ACS CHEMICAL BIOLOGY, 2020, 15 (06) : 1340 - 1348
  • [27] Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
    Hansen, Morten S. S.
    Tencerova, Michaela
    Frolich, Jacob
    Kassem, Moustapha
    Frost, Morten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 25 - 37
  • [28] Glucagon-Like Peptide-1 Receptor Agonists in the Management of Obesity: An Economics Meta-Analysis
    Bloomfield, Grace C.
    Chen, Yuan
    Cunningham, Marcus H.
    Bartoletti, Sebastiano
    Azagury, Dan E.
    Alimi, Yewande R.
    Prindeze, Nicholas
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S25 - S25
  • [29] Glucagon-like peptide-1 receptor is expressed in human and rodent testis
    Caltabiano, Rosario
    Condorelli, Daniele
    Panza, Salvatore
    Boitani, Carla
    Musso, Nicolo
    Jezek, Davor
    Memeo, Lorenzo
    Colarossi, Lorenzo
    Rago, Vittoria
    Mularoni, Valentina
    Spadola, Saveria
    Castiglione, Roberto
    Santoro, Marta
    Aquila, Saveria
    D'Agata, Rosario
    ANDROLOGY, 2020, 8 (06) : 1935 - 1945
  • [30] Glucagon-like peptide-1 receptor agonists ameliorate inflammation and fibrosis in an optimized rodentNASH model via inhibition of inflammatory macrophage activation
    Wang, X.
    Weng, S. -Y.
    Chen, T.
    Molokanova, O.
    Schattenberg, J.
    Klein, T.
    Schuppan, D.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S610 - S611
12345